These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25364986)

  • 1. Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathinones.
    Arfken CL; Owens D; Madeja C; DeAngelis C
    J Psychoactive Drugs; 2014; 46(5):362-8. PubMed ID: 25364986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergency of synthetic drugs in the general landscape of addiction].
    Karila L
    Rev Prat; 2012 May; 62(5):661-3. PubMed ID: 22730797
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
    Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
    Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States.
    Stogner JM; Miller BL
    Drug Alcohol Rev; 2013 Sep; 32(5):545-9. PubMed ID: 23718639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
    Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
    Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
    Khullar V; Jain A; Sattari M
    J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones.
    Fujita Y; Koeda A; Fujino Y; Onodera M; Kikuchi S; Niitsu H; Iwasaki Y; Usui K; Inoue Y
    Acute Med Surg; 2016 Jul; 3(3):230-236. PubMed ID: 29123790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cathinones: "a khat and mouse game".
    Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
    Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. University students' attributions for abstinence from synthetic cannabinoids and synthetic cathinones.
    Lauritsen KJ; Rosenberg H; Sprague JE
    Am J Drug Alcohol Abuse; 2018; 44(1):64-72. PubMed ID: 28267375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical challenges of synthetic cathinones.
    Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
    Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bath salts and polyconsumption: in search of drug-drug interactions.
    Lopez-Rodriguez AB; Viveros MP
    Psychopharmacology (Berl); 2019 Mar; 236(3):1001-1014. PubMed ID: 30911791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal overdose from synthetic cannabinoids and cathinones in Japan: demographics and autopsy findings.
    Ezaki J; Ro A; Hasegawa M; Kibayashi K
    Am J Drug Alcohol Abuse; 2016 Sep; 42(5):520-529. PubMed ID: 27283516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cannabinoid and cathinone use among US soldiers.
    Berry-Cabán CS; Kleinschmidt PE; Rao DS; Jenkins J
    US Army Med Dep J; 2012; ():19-24. PubMed ID: 23007932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.